Biotech & Health
Jessy··3 min read
World First: Japan Grants Regulatory Approval for iPS Cell Therapy
Japan has granted the world's first regulatory approval for the commercial sale of iPS cell-based medical treatments. This historic milestone, supported by extensive research in PubMed, transitions induced pluripotent stem cell technology from the laboratory to the clinic, positioning Japan as the global leader in regenerative medicine.
Jessy··3 min read